date,action,name,rate,target
Nov-30-18,Reiterated,Monness Crespi & Hardt,Buy,$175 to $185
Nov-30-18,Reiterated,BMO Capital Markets,Market Perform,$165 to $170
Jan-09-19,Initiated,Atlantic Equities,Overweight,$206
Feb-11-19,Reiterated,KeyBanc Capital Markets,Overweight,$179 to $216
Feb-26-19,Reiterated,Monness Crespi & Hardt,Buy,$185 to $220
Mar-01-19,Reiterated,Needham,Buy,$170 to $230
Mar-01-19,Reiterated,Monness Crespi & Hardt,Buy,$220 to $250
Mar-01-19,Reiterated,BofA/Merrill,Buy,$175 to $208
Mar-01-19,Reiterated,BMO Capital Markets,Outperform,$215 to $220
Mar-29-19,Initiated,Exane BNP Paribas,Underperform,
May-17-19,Reiterated,BofA/Merrill,Buy,$208 to $234
May-29-19,Reiterated,Monness Crespi & Hardt,Buy,$250 to $262
May-29-19,Reiterated,BMO Capital Markets,Market Perform,$220 to $230
